Global Microsampling Devices Market Strategic Research Report 2026-2031

Publication ID:

NAV1026027

Publication Date:

October 22, 2026

Pages:

223

Countries:

Global

$3,500.00

Buying Frequently for your Organization?

Click here to know more about our subscription packages.

Need Custom Market Research Solution?

Want to commission a custom market research to suit your needs? We are here to help. Let us know.

Printer version

Send by email

PDF version

Tabs

Description

The global microsampling devices market is valued at US$94.4 million in 2025 and is forecast to reach US$184.4 million by 2031, a compound annual growth rate (CAGR) of 11.8% over 2025-2031. Shipments are estimated at about 12.6 million units in 2025, rising to about 22.4 million units by 2031. Published third-party estimates for this market range from about US$94 million to US$2.4 billion because definitions differ widely, so the report adopts a narrow, clearly stated scope and a triangulated base of US$94.4 million.

Microsampling devices are compact collection tools that obtain small volumes of blood (typically under about 500 microliters) from a fingerstick or the upper arm for laboratory analysis, used in diagnostics, health screening, therapeutic drug monitoring and clinical trials. The scope covers volumetric absorptive microsampling (VAMS) devices, capillary self-collection devices, dried blood spot home-collection kits and microfluidic sampling cartridges. Bulk newborn-screening filter-paper cards, plain lancets, venous collection tubes, glucose-monitoring consumables, analyzers and service fees are excluded.

Scope of the Global Microsampling Devices Market Strategic Research Report

This report covers market value (US$ million) and unit volume (million units) for 2022-2031, with 2025 as the base year and 2026-2031 as the forecast period. It analyses type and application segments, five regions and 28 countries, five profiled companies, competitive structure, Porter's Five Forces, PESTLE, SWOT and future trends. No company discloses microsampling-specific revenue, so the report presents verified company facts and does not state company market shares or concentration ratios.

Segment by Type

Dried Blood Samples
Liquid Blood Samples

Segment by Application

Disease Diagnostics
Health Screening
Clinical Research
Others

Who Can Use This Report?

Microsampling device manufacturers and diagnostics groups benchmarking the market and its segments
Pharmaceutical sponsors, CROs and laboratories planning decentralised sample-collection strategies
Distributors and service providers assessing regional demand
Investors and corporate development teams evaluating the microsampling category

Table of Contents

1. Executive Summary
1.1 Market Definition and Scope
1.2 Market Size and Growth Trajectory
1.3 Principal Growth Drivers
1.4 Segment Highlights
1.5 Regional and Country Highlights
1.6 Competitive Structure
1.7 Principal Risks and Constraints
1.8 Outlook
2. Industry Overview & Forecast
2.1 Market Definition and Scope
2.2 Market Size and Historical Performance
2.3 Forecast and Growth Logic
2.4 Volume Analysis
2.5 Value Chain and Pricing Dynamics
3. Market Segmentation by Type
3.1 Overview of Type-Level Segmentation
3.1.1 Dried Blood Samples
3.1.2 Liquid Blood Samples
3.2 Volume Analysis
3.3 Comparative Mix Shift: Converging Revenue, Diverging Growth
4. Market Segmentation by Application
4.1 Overview of Application-Based Segmentation
4.1.1 Disease Diagnostics
4.1.2 Health Screening
4.1.3 Clinical Research
4.1.4 Others
4.2 Comparative Segment Analysis
5. Regional Market Forecast
5.1 North America
5.1.1 Regional Overview
5.1.2 Key Growth Drivers
5.1.3 Regulatory & Infrastructure Landscape
5.1.4 Country-Level Analysis
5.1.5 Market Forecast 2025–2031
5.2 Europe
5.2.1 Regional Overview
5.2.2 Key Growth Drivers
5.2.3 Regulatory & Infrastructure Landscape
5.2.4 Country-Level Analysis
5.2.5 Market Forecast 2025–2031
5.3 Asia Pacific
5.3.1 Regional Overview
5.3.2 Key Growth Drivers
5.3.3 Regulatory & Infrastructure Landscape
5.3.4 Country-Level Analysis
5.3.5 Market Forecast 2025–2031
5.4 Latin America
5.4.1 Regional Overview
5.4.2 Key Growth Drivers
5.4.3 Regulatory & Infrastructure Landscape
5.4.4 Country-Level Analysis
5.4.5 Market Forecast 2025–2031
5.5 Middle East and Africa
5.5.1 Regional Overview
5.5.2 Key Growth Drivers
5.5.3 Regulatory & Infrastructure Landscape
5.5.4 Country-Level Analysis
5.5.5 Market Forecast 2025–2031
6. Country-Level Market Forecast
6.1 North America
6.1.1 United States
6.1.2 Canada
6.1.3 Rest of North America
6.2 Europe
6.2.1 Germany
6.2.2 United Kingdom
6.2.3 France
6.2.4 Sweden
6.2.5 Netherlands
6.2.6 Italy
6.2.7 Rest of Europe
6.3 Asia Pacific
6.3.1 China
6.3.2 Japan
6.3.3 India
6.3.4 Australia
6.3.5 South Korea
6.3.6 Rest of Asia Pacific
6.4 Latin America
6.4.1 Brazil
6.4.2 Mexico
6.4.3 Argentina
6.4.4 Colombia
6.4.5 Rest of Latin America
6.5 Middle East and Africa
6.5.1 Saudi Arabia
6.5.2 United Arab Emirates
6.5.3 South Africa
6.5.4 Turkey
6.5.5 Rest of Middle East and Africa
7. Growth Drivers & Inhibitors
7.1 Executive Context
7.2 Growth Drivers
7.2.1 Accelerating Adoption of Decentralised and Remote Clinical Trial Models
7.2.2 Patient-Centric Healthcare and Home-Use Demand Dynamics
7.2.3 Bioanalytical Advances Elevating Microvolume Sample Utility
7.2.4 Regulatory Clearances Unlocking Commercial and Institutional Access
7.2.5 Distribution Network Expansion Into European and Global Markets
7.2.6 North American Market Leadership and Infrastructure Advantage
7.3 Market Restraints
7.3.1 Analytical Validation and Regulatory Compliance Burdens in Regulated Laboratories
7.3.2 Premium Unit Economics Relative to Conventional Collection Formats
7.3.3 Limited Commercial Scale and Market Concentration Risk
7.3.4 Heterogeneous Regulatory Classification Across Jurisdictions
7.3.5 Published Market Size Ambiguity Constraining Investor Confidence
7.4 Impact Assessment Summary
7.5 Integrated Assessment
8. Key Company Profiles
8.1 Trajan Scientific and Medical
8.1.1 Company Overview
8.1.2 Key Products & Segments
8.1.3 Financial Performance (2023–2025)
8.1.4 Business Strategy
8.1.5 SWOT Analysis
8.1.6 Strategic Implications (2025–2031)
8.2 Tasso
8.2.1 Company Overview
8.2.2 Key Products & Segments
8.2.3 Financial Performance (2023–2025)
8.2.4 Business Strategy
8.2.5 SWOT Analysis
8.2.6 Strategic Implications (2025–2031)
8.3 YourBio Health
8.3.1 Company Overview
8.3.2 Key Products & Segments
8.3.3 Financial Performance (2023–2025)
8.3.4 Business Strategy
8.3.5 SWOT Analysis
8.3.6 Strategic Implications (2025–2031)
8.4 Capitainer
8.4.1 Company Overview
8.4.2 Key Products & Segments
8.4.3 Financial Performance (2023–2025)
8.4.4 Business Strategy
8.4.5 SWOT Analysis
8.4.6 Strategic Implications (2025–2031)
8.5 BD (Becton Dickinson)
8.5.1 Company Overview
8.5.2 Key Products & Segments
8.5.3 Financial Performance (2023–2025)
8.5.4 Business Strategy
8.5.5 SWOT Analysis
8.5.6 Strategic Implications (2025–2031)
9. Competitive Landscape
9.1 Competitive Landscape Overview
9.1.1 Estimated Active Player Count
9.1.2 Profiled Companies: Verified Facts (No Share Estimates)
9.1.3 Concentration Metric
9.1.4 Structural Features Driving Fragmentation
9.1.5 Competitive Intensity Assessment
9.2 Competitive Intensity Assessment
9.2.1 Market Concentration and Tier Structure
9.2.2 Tier 1 Analysis
9.2.3 Tier 2 Analysis
9.2.4 Tier 3 Dynamics
9.2.5 Capacity vs. Demand Dynamics
9.2.6 Pricing Environment
9.2.7 Barriers to Entry and Exit
9.2.8 Competitive Intensity Conclusion
9.3 Key Player Strategies & Positioning
9.3.1 Strategic Group Map: Positioning Across the Competitive Landscape
9.3.2 Differentiation Strategies by Major Player
9.3.3 Geographic Strongholds
9.3.4 M&A and Partnership Activity, 2022–Present
9.3.5 R&D and Technology Investment Trends
9.4 Competitive Dynamics & Strategic Outlook
9.4.1 Market Structure at the Outset of the Forecast Period
9.4.2 Profiled Incumbents: Diverging Strategies
9.4.3 Emerging Competitive Threats
9.4.4 Consolidation vs. Fragmentation Outlook
9.4.5 Strategic Recommendations for Market Participants, 2025–2031
10. Porter's Five Forces Analysis
10.1 Threat of New Entrants
10.2 Bargaining Power of Buyers
10.3 Bargaining Power of Suppliers
10.4 Threat of Substitutes
10.5 Competitive Rivalry
11. PESTLE Analysis
11.1 Political
11.2 Economic
11.3 Sociocultural
11.4 Technological
11.5 Legal
11.6 Environmental
11.7 PESTLE Summary Table
12. SWOT Analysis
12.1 Industry SWOT Analysis
12.1.1 Detailed Analysis
12.1.1.1 Strengths
12.1.1.2 Weaknesses
12.1.1.3 Opportunities
12.1.1.4 Threats
12.1.2 Strategic Implications
13. Future Trends & Outlook
13.1 Trend Analysis
13.1.1 Decentralised and At-Home Blood Collection Becomes a Standard-of-Care Pathway
13.1.2 Regulatory Clearance Acceleration Unlocks Broader Addressable Markets
13.1.3 Clinical Research Adoption Drives Repeat-Purchase Revenue Streams
13.1.4 Venture Capital and Strategic Investment Sustains Platform Innovation
13.1.5 Distribution Network Expansion into Europe and Asia-Pacific Accelerates Growth
13.1.6 Technological Convergence
13.1.7 Market Segmentation Deepening
13.1.8 Market Fragmentation and Consolidation Pressure Create M&A Opportunity
13.2 Trend Summary Table
13.3 Forward Outlook (2026–2031)

List of Exhibits
Exhibit 2.1: Forecast of Global Market YoY Growth Rate & CAGR Summary (in %)
Exhibit 2.2: Forecast of Global Market YoY Growth Rate & CAGR Summary (in %)
Exhibit 2.3: Forecast of Global (in USD Mn)
Exhibit 2.4: Forecast of North America (in USD Mn)
Exhibit 2.5: Forecast of Europe (in USD Mn)
Exhibit 2.6: Forecast of Asia Pacific (in USD Mn)
Exhibit 2.7: Forecast of Latin America (in USD Mn)
Exhibit 2.8: Forecast of Middle East and Africa (in USD Mn)
Exhibit 2.9: Forecast of Global (in Mn Units)
Exhibit 2.10: Forecast of North America (in Mn Units)
Exhibit 2.11: Forecast of Europe (in Mn Units)
Exhibit 2.12: Forecast of Asia Pacific (in Mn Units)
Exhibit 2.13: Forecast of Latin America (in Mn Units)
Exhibit 2.14: Forecast of Middle East and Africa (in Mn Units)
Exhibit 3.15: Forecast of Dried Blood Samples (in USD Mn)
Exhibit 3.16: Forecast of Dried Blood Samples (in Mn Units)
Exhibit 3.17: Forecast of Liquid Blood Samples (in USD Mn)
Exhibit 3.18: Forecast of Liquid Blood Samples (in Mn Units)
Exhibit 4.19: Forecast of Disease Diagnostics (in USD Mn)
Exhibit 4.20: Forecast of Disease Diagnostics (in Mn Units)
Exhibit 4.21: Forecast of Health Screening (in USD Mn)
Exhibit 4.22: Forecast of Health Screening (in Mn Units)
Exhibit 4.23: Forecast of Clinical Research (in USD Mn)
Exhibit 4.24: Forecast of Clinical Research (in Mn Units)
Exhibit 4.25: Forecast of Others (in USD Mn)
Exhibit 4.26: Forecast of Others (in Mn Units)
Exhibit 6.27: Forecast of North America (in USD Mn)
Exhibit 6.28: Forecast of United States (in USD Mn)
Exhibit 6.29: Forecast of Canada (in USD Mn)
Exhibit 6.30: Forecast of Rest of North America (in USD Mn)
Exhibit 6.31: Forecast of North America (in Mn Units)
Exhibit 6.32: Forecast of United States (in Mn Units)
Exhibit 6.33: Forecast of Canada (in Mn Units)
Exhibit 6.34: Forecast of Rest of North America (in Mn Units)
Exhibit 6.35: Forecast of Europe (in USD Mn)
Exhibit 6.36: Forecast of Germany (in USD Mn)
Exhibit 6.37: Forecast of United Kingdom (in USD Mn)
Exhibit 6.38: Forecast of France (in USD Mn)
Exhibit 6.39: Forecast of Sweden (in USD Mn)
Exhibit 6.40: Forecast of Netherlands (in USD Mn)
Exhibit 6.41: Forecast of Italy (in USD Mn)
Exhibit 6.42: Forecast of Rest of Europe (in USD Mn)
Exhibit 6.43: Forecast of Europe (in Mn Units)
Exhibit 6.44: Forecast of Germany (in Mn Units)
Exhibit 6.45: Forecast of United Kingdom (in Mn Units)
Exhibit 6.46: Forecast of France (in Mn Units)
Exhibit 6.47: Forecast of Sweden (in Mn Units)
Exhibit 6.48: Forecast of Netherlands (in Mn Units)
Exhibit 6.49: Forecast of Italy (in Mn Units)
Exhibit 6.50: Forecast of Rest of Europe (in Mn Units)
Exhibit 6.51: Forecast of Asia Pacific (in USD Mn)
Exhibit 6.52: Forecast of China (in USD Mn)
Exhibit 6.53: Forecast of Japan (in USD Mn)
Exhibit 6.54: Forecast of India (in USD Mn)
Exhibit 6.55: Forecast of Australia (in USD Mn)
Exhibit 6.56: Forecast of South Korea (in USD Mn)
Exhibit 6.57: Forecast of Rest of Asia Pacific (in USD Mn)
Exhibit 6.58: Forecast of Asia Pacific (in Mn Units)
Exhibit 6.59: Forecast of China (in Mn Units)
Exhibit 6.60: Forecast of Japan (in Mn Units)
Exhibit 6.61: Forecast of India (in Mn Units)
Exhibit 6.62: Forecast of Australia (in Mn Units)
Exhibit 6.63: Forecast of South Korea (in Mn Units)
Exhibit 6.64: Forecast of Rest of Asia Pacific (in Mn Units)
Exhibit 6.65: Forecast of Latin America (in USD Mn)
Exhibit 6.66: Forecast of Brazil (in USD Mn)
Exhibit 6.67: Forecast of Mexico (in USD Mn)
Exhibit 6.68: Forecast of Argentina (in USD Mn)
Exhibit 6.69: Forecast of Colombia (in USD Mn)
Exhibit 6.70: Forecast of Rest of Latin America (in USD Mn)
Exhibit 6.71: Forecast of Latin America (in Mn Units)
Exhibit 6.72: Forecast of Brazil (in Mn Units)
Exhibit 6.73: Forecast of Mexico (in Mn Units)
Exhibit 6.74: Forecast of Middle East and Africa (in USD Mn)
Exhibit 6.75: Forecast of Saudi Arabia (in USD Mn)
Exhibit 6.76: Forecast of United Arab Emirates (in USD Mn)
Exhibit 6.77: Forecast of South Africa (in USD Mn)
Exhibit 6.78: Forecast of Turkey (in USD Mn)
Exhibit 6.79: Forecast of Rest of Middle East and Africa (in USD Mn)
Exhibit 6.80: Forecast of Middle East and Africa (in Mn Units)
Exhibit 6.81: Forecast of Saudi Arabia (in Mn Units)
Exhibit 6.82: Forecast of United Arab Emirates (in Mn Units)
Exhibit 6.83: Forecast of South Africa (in Mn Units)

Companies Covered

Trajan Scientific and Medical
Tasso
YourBio Health
Capitainer
BD (Becton Dickinson)

Report License Types

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Enterprise license fee.

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Enterprise license fee.

Enterprise License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

Report Enquiry

Buying Frequently for your Organization?

Need Custom Market Research Solution?

Tabs

Single User License (PDF)

Site License (PDF)*

Enterprise License (PDF)*

Latest Market Research Reports

Global Wearable Ultrasound Devices Market

Global Humanoid Robot E-Skin Market Strategic

Global Large Format Plotter Printer Market

Global Float Collar and Float Shoe Market

Global Hydrocephalus Shunt System Market

Global Microsampling Devices Market Strategic

About Us

Infomation